Inogen Inc (INGN) is a publicly traded Healthcare sector company. As of May 21, 2026, INGN trades at $6.07 with a market cap of $170.57M and a P/E ratio of -6.88. INGN moved -1.71% today. Year to date, INGN is -4.66%; over the trailing twelve months it is +1.12%. Its 52-week range spans $5.34 to $12.91. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces INGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
INGN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. INGN recently traded at $6.07. Market cap is $170.57M. P/E ratio is -6.88. Revenue is $351.50M.
| Metric | Value |
|---|---|
| Price | $6.07 |
| Market Cap | $170.57M |
| P/E Ratio | -6.88 |
| EPS | $-0.92 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.91 |
| 52-Week Low | $5.34 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $351.50M |
| Net Income | $-24.90M |
| Gross Margin | 44.31% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $348.67M | $-22.75M | $-0.86 |
| 2023 | $315.66M | $-102.45M | $-4.42 |
| 2022 | $377.24M | $-83.77M | $-3.67 |
| 2021 | $358.00M | $-6.33M | $-0.28 |
2 analysts cover INGN: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.